Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
accreted, accretion, Aimovig, Ajovy, annum, ATM, atogepant, Azelby, Bellina, Biohaven, Blueprint, brain, bundled, California, Campoy, chain, Cleveland, Cloud, collateralized, constraint, customary, deserve, detract, dispute, disputed, dissolution, District, element, Elisabeth, Emgality, encompassing, Erin, exit, forgo, Frank, FRCP, freestanding, gastrointestinal, GDPR, Goodwill, greatest, harbor, HCP, HHS, immaterial, implicit, incentivize, inconsequential, incremental, indemnification, Inspector, intrinsic, involuntary, irrevocable, Jersey, Jordan, Judge, Lavelle, ligand, LTIP, Matthew, McLinn, Mongiello, Morgan, multiplied, neurogenic, neutralizing, Nonemployee, notification, PACAP, pathophysiology, Paul, PDUFA, Pennsylvania, PK, pocket, predominant, processing, proportionally, pure, ramp, Randy, ratably, reactivity, redemption, residual, restarted, rimegepant, Robert, ROU, RSU, Sandoval, Sandoz, shrink, signaling, sixty, spanning, SSP, standby, strict, successor, symptomatology, Timothy, Trickett, unamortized, unapproved, unconstitutional, unpaid, unsecured, upgrade, Wendler, whichever, Whitaker, winding
Removed:
approvable, assured, BESP, BMS, calling, characterized, collectability, convene, copy, curtailed, decided, deliverable, depict, disability, Dow, engineered, excretion, extension, feedback, figure, fluctuation, footage, forego, genetically, illustrated, impossible, insight, interaction, intervention, IPO, launched, leased, nonstatutory, persuasive, rationale, realizable, room, sensitivity, separable, sharp, Squibb, Stephen, suggested, task, throbbing, today, toxicity, TPE, undelivered, validate, variance, Vice, VSOE
Filing tables
Filing exhibits
ALDR similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-216199) and Form S‑8 (Nos. 333-195807, 333-202738, 333-209663, 333-216198, 333-223239, and 333-226714) of Alder BioPharmaceuticals, Inc., of our report dated February 25, 2019 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Seattle, Washington
February 25, 2019